Vanguard Asset Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$55.3M Buy
149,226
+11,036
+8% +$3.9M 0.03% 404
2026
Q2
$49.6M Buy
138,190
+13,548
+11% +$4.14M 0.03% 411
2026
Q1
$31.2M Buy
+124,642
New +$31M 0.03% 472

Other funds holding WST

Vanguard Asset Management's WST Position: Q3 2026 in Review

Vanguard Asset Management increased its West Pharmaceutical (WST) stake by 8% in Q3 2026, buying an estimated $3.9M and bringing the position to 149,226 shares worth $55.3M. The position accounts for 0.03% of the portfolio, ranked #404.

Vanguard Asset Management first reported a position in WST in Q1 2026 and has held it in 3 quarters since. 789 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Vanguard Asset Management held 149,226 shares of West Pharmaceutical worth $55.3M as of Q3 2026.
  • Vanguard Asset Management bought 11,036 West Pharmaceutical shares in Q3 2026, an estimated $3.9M.
  • West Pharmaceutical made up 0.03% of Vanguard Asset Management's portfolio in Q3 2026, its #404 holding.
  • Vanguard Asset Management first reported a position in West Pharmaceutical in Q1 2026 and has held it in 3 quarters since.
  • 789 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.